Calculate The Estimate Survival Benefit of Adjuvant TACE After Curative Resection for Hepatocellular Carcinoma
Estimates the expected net survival benefit of adjuvant transcatheter arterial chemoembolization in patients after curative-intent hepatectomy for hepatocellular carcinoma.
INSTRUCTIONS
The calculator applies the study’s two nomogram models—one assuming adjuvant TACE and one assuming no adjuvant TACE—then reports the difference between the two predictions as the estimated net survival benefit of adjuvant TACE.
